STOCK TITAN

Cardiff Oncology, Inc. (CRDF) Revenue by Year

CRDF

Cardiff Oncology, Inc. generated $593K in revenue in fiscal year 2025. This represents a decrease of 13.2% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $508K in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Cardiff Oncology, Inc. has filed alongside them.

FY2025 annual
Revenue $593K
YoY -13.2%
5Y CAGR +10.1%
10Y CAGR +6.6%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CRDF Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$508K$593K-13.2%$683K+40.0%$488K+26.4%$386K+7.5%$359K-1.9%$366K+49.6%$245K-35.3%$378K-25.1%$505K+32.6%$381K+21.8%$313K+11.6%$280K+8.1%$259K-42.4%$450K+74.8%$258K

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

CRDF Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$104K-14.0%$41K-62.4%$243K+62.0%$120K-27.3%$121K-25.8%$109K-46.8%$150K-3.8%$165K+17.0%$163K+50.9%$205K+147.0%$156K+21.9%$141K+51.6%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Cardiff Oncology, Inc. financials

Frequently Asked Questions

What was Cardiff Oncology, Inc.'s revenue in fiscal year 2025?

Cardiff Oncology, Inc. generated $593K in revenue in fiscal year 2025.

How fast is Cardiff Oncology, Inc.'s revenue growing?

Cardiff Oncology, Inc. (CRDF) revenue fell by 13.2% year over year, from $683K to $593K in fiscal year 2025.

What is Cardiff Oncology, Inc.'s revenue over the last twelve months?

Cardiff Oncology, Inc. (CRDF) reported $508K in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Cardiff Oncology, Inc. (CRDF) revenue went from $258K in fiscal year 2011 to $593K in fiscal year 2025.

Cardiff Oncology, Inc. (CRDF) reported $104K in revenue in Q2 2026. This represents a decrease of 14.0% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Cardiff Oncology, Inc. (CRDF) reported on that line in every period on record.